English Korean Chinese
ホーム > 市場調査レポート > バイオテクノロジー > バイオ機器 > 米国における新興の感染症検査向け分子診断の市場
カテゴリ
バイオテクノロジー (1630)
オーダーメイド医療 (51)
ゲノム創薬 (203)
バイオマーカー (158)
バイオマテリアル (54)
バイオ機器 (385)
遺伝子療法/RNAi (103)
抗体/免疫 (194)
再生医療 (122)
分子標的療法 (132)
市場調査レポート

米国における新興の感染症検査向け分子診断の市場

U.S. Molecular Diagnostics Markets for Emerging Infectious Disease Tests

発行 Frost & Sullivan
出版日 2008年12月 商品コード 79861
ページ情報 英文 65 Pages
価格
US$ 6,000 換算 ¥ 482,820 (税抜) Web Access (Regional License)
US$ 6,500 換算 ¥ 523,055 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

This research service analyzes the market for emerging infectious disease molecular diagnostics within the United States. The United States market was divided into the HPV molecular diagnostics and MRSA molecular diagnostics market segments.

Table of Contents

1. EXECUTIVE SUMMARY

Market Overview

  • Introduction

2. EMERGING INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKETS

Market Overview

  • Introduction
  • Research Methodology

Market Segmentation and Market Sizes

  • Scope and Segmentation
  • Market Sizes

3. HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET

Market Overview

  • Introduction
  • Market Engineering Measurements

Market Challenges and Strategic Recommendations

  • Market Challenges
  • Strategic Recommendations

Market Drivers and Restraints

  • Market Drivers
  • Market Restraints

Market and Technology Trends

  • Market Trends
  • Technology Trends

Market Forecasts

  • Revenue Forecasts

Competitive Analysis

  • Competitive Structure
  • Market Share Analysis
  • Product Analysis

4. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS MOLECULAR DIAGNOSTICS MARKET

Market Overview

  • Introduction
  • Market Engineering Measurements

Market Challenges and Strategic Recommendations

  • Market Challenges
  • Strategic Recommendations

Market Drivers and Restraints

  • Market Drivers
  • Market Restraints

Market and Technology Trends

  • Market Trends
  • Technology Trends

Market Forecasts

  • Revenue Forecasts

Competitive Analysis

  • Competitive Structure
  • Market Share Analysis
  • Product Analysis

5. DECISION SUPPORT DATABASES

Decision Support Databases

  • Number of Hospitals
Back to Top